CompaniesByCap
CBIO
Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare

Crescent Biopharma, Inc. Cash Flow 2012–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Operating Activities
Operating Cash Flow-71.5M-31.1M-34.9M-46.5M-57.5M-39.2M-52.0M-43.3M-29.8M-29.7M-8.2M
Depreciation & Amort.
Investing Activities
Capital Expenditure919,0009,97221,39484,19114,94368,507144,928125,618294,107704,202268,594
Free Cash Flow-72.5M-31.1M-34.9M-46.5M-57.5M-39.3M-52.1M-43.5M-30.1M-30.4M-8.5M
Financing Activities
Dividends Paid
Stock Buybacks

Crescent Biopharma, Inc. Cash Flow — FAQ

Crescent Biopharma, Inc. (CBIO) cash flow over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CBIO's cash flow history?

The chart and table above show Crescent Biopharma, Inc.'s cash flow by year and by quarter, including the growth rate.